coronavirus antibodies

The drug combination from Regeneron Pharmaceuticals cut patient deaths from 30% to 24% among those who hadn’t already developed an immune response against COVID-19.

Regeneron says tests in more than 4,000 recently diagnosed patients found its two-antibody combo drug cut the risk of hospitalization or death by 70%.

Doctors say not enough people in South Florida seem to know about the treatment — an infusion of antibodies — that can prevent symptoms from worsening and stave off hospitalization or death.

A rheumatologist in Miami-Dade seeks volunteers for a double-blind, placebo-controlled pilot study to test a drug that would treat COVID-19 long-hauler syndrome.

The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on hospitalized COVID-19 patients. Researchers concluded the antibody treatment was "unlikely to help."

The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.

Iran has surpassed 20,000 confirmed deaths from the coronavirus.Wednesday's announcement comes as Iran struggles with the largest outbreak in the Middle…

Veterans hospitals across Florida are understaffed and the Veterans Healthcare Policy Institute says the pressures the coronavirus pandemic has put on the…

State Rep. Shevrin Jones is the first — and only — out, gay, Black member of the Florida Legislature.He’s also a survivor of COVID-19.He, his brother and…

Scientists are now checking to see if purified blood serum from people who have recovered from COVID-19 might be more than a useful treatment. Perhaps it's a way to prevent disease in someone else.